Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 17
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/11/2008
First Published:
12/1/1998
1.
Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Stage IV Adrenal Gland Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
6 months and over
Other
BC-AD-2
NCT00003453
Last Modified:
11/2/2007
First Published:
11/1/1998
2.
Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Severe Brain Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
BC-BT-9
NCT00003457
Last Modified:
11/2/2007
First Published:
11/1/1998
3.
Phase II Study of Antineoplastons A10 and AS2-1 in Children With Brain Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
6 months to 17 years
Other
BC-BT-10
NCT00003458
Last Modified:
11/2/2007
First Published:
11/1/1998
4.
Phase II Study of Antineoplastons A10 and AS2-1 in Children With Primitive Neuroectodermal Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
6 months to 17 years
Other
BC-BT-12
NCT00003460
Last Modified:
1/30/2008
First Published:
11/1/1998
5.
Phase II Study of Antineoplastons A10 and AS2-1 in Children With Low-Grade Astrocytoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
6 months to 17 years
Other
BC-BT-13
NCT00003468
Last Modified:
11/2/2007
First Published:
11/1/1998
6.
Phase II Study of Antineoplastons A10 and AS2-1 in Children With Rhabdoid Tumors of the Central Nervous System
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
6 months to 17 years
Other
BC-BT-14
NCT00003469
Last Modified:
1/11/2008
First Published:
12/1/1998
7.
Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Anaplastic Astrocytoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
BC-BT-15
NCT00003470
Last Modified:
11/2/2007
First Published:
11/1/1998
8.
Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Recurrent or Refractory Oligodendroglioma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
BC-BT-17
NCT00003472
Last Modified:
11/2/2007
First Published:
11/1/1998
9.
Phase II Study of Antineoplastons A10 and AS2-1 in Adults with Mixed Gliomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
BC-BT-18
NCT00003473
Last Modified:
11/2/2007
First Published:
11/1/1998
10.
Phase II Study of Antineoplastons A10 and AS2-1 in Adults With Primary Malignant Brain Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
BC-BT-21
NCT00003475
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
